Lupin Enters Brazil’s Prescription Dermatology Segment With Two Products
An employee holds Ramipril capsules for a photograph inside a coating unit at the Lupin Ltd. pharmaceutical plant in Salcette, Goa, India. (Photographer: Dhiraj Singh/Bloomberg)

Lupin Enters Brazil’s Prescription Dermatology Segment With Two Products

Bookmark
Drug maker Lupin Ltd. today said it has entered the prescription dermatology segment in Brazil with the launch of its two products, Fillerina and Recrexina, in the country.“The launch of Lupin high...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.